Wegovy (Semaglutide) is a glucagon-like peptide-1 (GLP-1) receptor agonist indicated as an adjunct to a reduced-calorie diet and increased physical activity for chronic weight management. It serves as a physiological mimetic of the natural GLP-1 hormone, targeting cerebral receptors to regulate appetite, enhance satiety, and stabilize postprandial glucose levels.

Dosage & Administration

• Dosage: Adhere strictly to the dosing schedule and administration instructions provided by your physician.
• Method: Subcutaneous injection into the abdomen, thigh, or upper arm.
• Cycle: One FlexTouch pen contains 4 doses.

Technical Specification

• Form: Multi-dose pre-filled delivery device (FlexTouch).
• Active Ingredient: Semaglutide.
• Included Components: 1 pre-filled pen and 4 disposable needles.

Ingredient Functionality

• Semaglutide: Acts as a GLP-1 receptor agonist with 94% sequence homology to human GLP-1. It prolongs half-life to approximately 1 week by increasing albumin binding and stability against DPP-4 enzymatic degradation.
• Appetite Regulation: Modulates hunger signals in the hypothalamus, leading to a significant reduction in caloric intake.
• Insulin Secretion: Stimulates glucose-dependent insulin release from pancreatic beta cells while suppressing inappropriate glucagon secretion.

Safety & Storage

• Initial Storage: Store unopened pens in a refrigerator at 2°C to 8°C. Do not freeze.
• In-Use Storage: After first use, the pen may be stored for up to 6 weeks either in the refrigerator or at room temperature (30°C).
• Light Protection: Keep the pen cap on when not in use to protect the solution from light.